AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2025

Nov 10, 2025

32870_dirs_2025-11-10_6e2eca12-a2b8-493b-abc4-6ba6938a8ac9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2025-11-07

Reporting Person: Dayal Sujata Tyagi (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-07	Common Stock	S	8552	$10	Disposed	88980	Direct

Footnotes

F1: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on August 8, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F2: All shares sold at an exact price of $10.00.